| Bioactivity | Omigapil maleate, an orally bioavailable GAPDH nitrosylation inhibitor, abrogates Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. Omigapil maleate has the potential for the research of Alzheimer's disease[1]. Omigapil maleate (CGP3446B maleate) is a apoptosis inhibitor. Omigapil maleate can be used for the research of congenital muscular dystrophy (CMD)[2]. |
| Name | Omigapil maleate |
| CAS | 200189-97-5 |
| Formula | C23H21NO5 |
| Molar Mass | 391.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Omigapil maleate
CAS: 200189-97-5 F: C23H21NO5 W: 391.42
Omigapil maleate, an orally bioavailable GAPDH nitrosylation inhibitor, abrogates Aβ1-42-induced tau acetylation, memor
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.